Navigation Links
By Targeting Specific Germs, Hospital Hopes to Improve Pneumonia Treatment

e at higher risk of dying.”

To improve the effectiveness of therapy, national guidelines recommend that hospitals base drug selection on the characteristics of the bacteria in their institutions. However, specific recommendations on how to accomplish this are not widely agreed on. Wake Forest Baptist’s report is believed to the first published description of a process using hospital data on infection-causing bacteria to develop institution-specific guidelines for treatment of pneumonia.

The Medical Center project was part of an overall effort to improve care of pneumonia acquired in the hospital. Team members reviewed six months of pneumonia cases from 2004 – a total of 115 cases – to learn which bacteria had caused the pneumonia. They found that at Baptist Hospital, it was patients who had been hospitalized at least 10 days who were most at risk of being infected with bacteria resistant to the most common antibiotics.

The group analyzed each episode of late-onset pneumonia to determine the adequacy of various drug combinations. The goal was to determine which drugs should be used and under what circumstances. They are currently looking at 2006 pathogens to see if the bacteria have changed – which could require an update of the internal guidelines.

In addition to making sure that patients get the most effective therapy, the project also helps the hospital be better stewards of antibiotics, Beardsley said.

“Improper use of antibiotics – whether it is under-dosing, over-use, or prescribing a drug that isn’t effective against the pathogen – hurts our ability to treat the next infected person because resistance can develop,” he said.

Sorce-Newswise
SRM
'"/>




Page: 1 2

Related medicine news :

1. Novel Technique For Targeting Small-Cell Lung Cancer
2. Targeting PARP1 Is Effective In Protecting HD Cells from Damage
3. Ad Campaign Targeting Republicans On Medicare Prescription Drug Program
4. Highly Potent TB Strain Plays Favorites Targeting Specific Ethnic Groups
5. New Asthma Medicine Targeting Vulnerable Inner-City Children Tested
6. Targeting a Single Gene Could Inhibit Bone Decay and Stimulate Bone Growth
7. Researchers Find Stem-cell Therapy Effective in Targeting Metastatic Cancer
8. Targeting the Adrenal Gland Could Be Key Against Heart Failure
9. Targeting SOCS-3 can Control Obesity
10. Sex Abstinence Programs Targeting School-goers may Not Produce Desired Effect , Study
11. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
Post Your Comments:
(Date:10/8/2008)... HIV-test-kit.com is a new site aimed a....V. from the comfort and privacy of their own home... issue. It is hoped that through home tests more p...he AIDS virus. , New York...eople are getting more used to getting instant res...
(Date:10/8/2008)... Drug Information Association (DIA) wil...-7; Ottawa, Ontario, Canada) to discuss a number o...aceutical industry, health academia, and the healt... PA (PRWEB) October 8, 2008 -- The http://www.diah... host the http://www.diahome.org/diahome/FlagshipM...
(Date:10/8/2008)... AccurateAnswers™ support program...es for http://www.appointment-plus.com [online s... Scottsdale, AZ (PRWEB) October 8, 2008 -- ... scheduling software, continues to expand its soft...n most "software as a service" providers...
(Date:10/8/2008)... Juva Skin & Laser Center is well e...kin treatments in New York City. The facility is l...e, one of the latest skin resurfacing treatments t...e laser equipment. , New ...urgery and laser treatment industry is in the mids...
Breaking Medicine News(10 mins):Health News:HIV Test Kit Markets a New Development in the War Against the AIDS Virus, an Easy Home HIV Testing Device 2Health News:DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress 2Health News:Appointment-Plus Continues Innovation With Technical Support Program 2Health News:Upscale New York City Skin Care Center Juva Offering FDA Approved Fraxel re:fine System 2
...n therapy with the new biologic drug adalimumab an...es more effective for people with long-standing rh...gement // with methotrexate alone. It has been fou...ents who fail to respond to standard treatment. A...
... Duke Univ. has shown that the surgical outcome of...n non-diabetics. The results were published Aug. 1...// In the largest analysis of its kind, Duke Univ... found that patients with diabetes who require sur...
...s had said that short-acting Beta-agonist (SABA) p...or asthma morbidity of steroid and non-steroid use...Illinois Medicaid, with a diagnosis of asthma from...esearchers from Chicago, IL, obtained the claims f...
...cer does not discriminate between rich and poor, i...ebrities have succumbed to it and some have fought...mous// actresses and personalities who have suffer...ton-John -Actress and SingerShirley Temple Black -...
Other Medicine News:Health News:Ankle Fracture Surgery – Diabetics fare worse than non-diabetics 2Health News:Ankle Fracture Surgery – Diabetics fare worse than non-diabetics 3
(Date:10/6/2008)... - Data Presented at ACG Annual Scient...ire/ -- Ironwood Pharmaceuticals,(formerly Microbi...r of,preclinical studies delineating the role that...leviating intestinal pain. These studies,demonstra...ical model of,intestinal hyperalgesia and desensit...
(Date:10/6/2008)... Experts Discuss Promising Research at The Amer... Annual Meeting, WASHINGTON, Oct. 6 /PRNewswir...n children and seniors was presented at The Americ...symposium, "Practical Applications of,Probiotics i...ields of,pediatrics, aging, and nutrition discusse...
(Date:10/6/2008)... PLYMOUTH MEETING, Pa., Oct. 6 /PRNewswire-Fi...oday reported data from its second Phase 1,clinica...d drug candidate,for the treatment of type 2 diabe...PTP1B, a validated molecular target that controls ...ys to normalize glucose and decrease,appetite. In ...
(Date:10/6/2008)... - Conference Call Scheduled for 9:0...tCall/ -- Dendreon Corporation (Nasdaq:,DNDN) anno...rim analysis of,the Phase 3, randomized, double-bl...Prostate AdenoCarcinoma Treatment, also known as D...y and efficacy of the,investigational active cellu...
Breaking Medicine Technology:Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Louisiana Tech researchers investigate tracking sensors to assist Air Force 324 1Louisiana Tech researchers investigate tracking sensors to assist Air Force 324 2Louisiana Tech researchers investigate tracking sensors to assist Air Force 324 3Small Incisions Make Heart Valve Surgery Safer 918 1Small Incisions Make Heart Valve Surgery Safer 918 2Small Incisions Make Heart Valve Surgery Safer 918 3 26 239 3BDrug free treatments offer hope for older people in pain 915 1Medifast Announces Winners of Mother Daughter Challenge 912 1Medifast Announces Winners of Mother Daughter Challenge 912 2Medifast Announces Winners of Mother Daughter Challenge 912 3
...ested in Patients Reduces,Severity of Adult Leukae... the Danish,biopharmaceutical company, announced t...t of Bcl-2, has shown early evidence of,efficacy i...Lymphocytic Leukaemia (CLL). The results of the st...ting of the American Society of,Clinical Oncology,...
...7 - Inovio Biomedical,Corporation (AMEX:INO), focu... and infectious diseases and a novel alternative t...day the company,delivered multiple presentations o...ions relating to its electroporation-mediated DNA,...the American,Society of Gene Therapy (ASGT). Inovi...
Other Medicine Technology:Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 2Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 3Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 4Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 5Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 6Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 7Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 8Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 9Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 2Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 3Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 4Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 5
...ydroepiandrosterone sulfate (DHEA-S) is the sulfat...and by enzymatic conversion of DHEA in adrenal and...d secreted by the adrenal cortex, and is a precurs...A possesses relatively weak androgenic activity, w...
EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM.
The Diamedix immunosimplicity® Is- Rheumatoid Factor Test Kit is an EIA procedure intended for the quantitation of IgM antibodies to IgG antigen. The results are reported in IU/mL, traceable to t
The SYNCHRON CX4 Delta Specialty / Drug Clinical System is a random access analyzer that can consolidate Drugs of Abuse, TDM's and other specialty testing, such as thyroid, HbA1c and lipids in one co
Medicine Products: